{
"@context": "https://schema.org",
"@type": "Article",
"headline": "S.D. Texas: PMA Preemption and <em>Twiqbal</em> Doom Stent Graft Warnings and Manufacturing Defect Claims",
"url": "https://www.lexblog.com/2023/04/28/s-d-texas-pma-preemption-and-twiqbal-doom-stent-graft-warnings-and-manufacturing-defect-claims/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-3XTXWVGR",
"url": "https://www.lexblog.com/lib/3XTXWVGR/"
},
"datePublished": "2023-04-28T04:00:00-04:00",
"dateModified": "2023-04-28T05:10:24-04:00",
"author": {
"@type": "Person",
"name": "Rachel B. Weil"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Drug & Device Law Blogging Team"
},
"organizationScope": "at-publication",
"isPartOf": "Drug & Device Law",
"about": "Business and Commercial",
"sourceUrl": "https://www.druganddevicelawblog.com/?p=41742",
"sourceStability": "may-move"
}